BDBM199501 5-fluoro-n-((1r,5s,7s)-9-methyl-3-oxa-9- azabicyclo[3.3.1]nonan-7-yl)-1-(pyridin-3- yl)-1h-pyrrolo[2,3-b]pyridine-3- carboxamide, 2,2,2-trifluoroacetic acid salt::US10125145, Cpd. No. 13::US9670229, 13

SMILES CN1C2COCC1CC(C2)NC(=O)c1cn(-c2cccnc2)c2ncc(F)cc12

InChI Key InChIKey=XLIZJIRFMQBIQB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 199501   

Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199501(5-fluoro-n-((1r,5s,7s)-9-methyl-3-oxa-9- azabicycl...)
Affinity DataIC50:  0.720nMAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199501(5-fluoro-n-((1r,5s,7s)-9-methyl-3-oxa-9- azabicycl...)
Affinity DataIC50:  0.720nMT: 2°CAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent